News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Crowley Elizabeth
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/03/2021 |
4
| Crowley Elizabeth (Sr. VP &CPDO) has filed a Form 4 on Celldex Therapeutics, Inc.
Txns:
| Sold 2,528 shares
@ $44.116, valued at
$111.5k
Sold 600 shares
@ $43.113, valued at
$25.9k
Sold 1,189 shares
@ $41.616, valued at
$49.5k
Exercised 8,555 options to buy
@ $2.78, valued at
$23.8k
|
|
06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/19/2020 |
4
| Crowley Elizabeth (Sr. VP &CPDO) has filed a Form 4 on Celldex Therapeutics, Inc.
Txns:
| Granted 84,000 options to buy
@ $10.38, valued at
$871.9k
|
|
06/20/2019 |
4
| Crowley Elizabeth (Sr. VP &CPDO) has filed a Form 4 on Celldex Therapeutics, Inc.
Txns:
| Granted 43,000 options to buy
@ $2.78, valued at
$119.5k
|
|
06/15/2018 |
4
| Crowley Elizabeth (Sr. VP &CPDO) has filed a Form 4 on Celldex Therapeutics, Inc.
Txns:
| Granted 300,000 options to buy
@ $0.6011, valued at
$180.3k
|
|
06/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/12/2016 |
3
| Crowley Elizabeth (SVP, Chief Product Dev Officer) has filed a Form 3 on Celldex Therapeutics, Inc. |
|
|